BenzingaOctober 13, 2026 at 9:09 AM NY14 Days Ago
HC Wainwright & Co. Maintains Buy on AngioDynamics, Lowers Price Target to $18
HC Wainwright & Co. analyst Yi Chen maintains AngioDynamics (NASDAQ:ANGO) with a Buy and lowers the price target from $19 to $18.
What This Story Means
Claude is explaining the story in plain words…
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: Benzinga
